The store will not work correctly when cookies are disabled.
7-Chloro-11H-indeno[2,3-b]quinoxalin-11-one oxime
ID: ALA4583031
PubChem CID: 155565897
Max Phase: Preclinical
Molecular Formula: C15H8ClN3O
Molecular Weight: 281.70
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O/N=C1/c2ccccc2-c2nc3cc(Cl)ccc3nc21
Standard InChI: InChI=1S/C15H8ClN3O/c16-8-5-6-11-12(7-8)18-13-9-3-1-2-4-10(9)14(19-20)15(13)17-11/h1-7,20H/b19-14-
Standard InChI Key: UUCUQQSPAIGSDY-RGEXLXHISA-N
Molfile:
RDKit 2D
20 23 0 0 0 0 0 0 0 0999 V2000
28.1463 -26.8311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1451 -27.6506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8532 -28.0596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8514 -26.4222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5600 -26.8275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5608 -27.6465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2693 -28.0536 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.2637 -26.4172 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.9728 -26.8206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9805 -27.6397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7618 -27.8856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7495 -26.5603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2349 -27.2186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0458 -27.1266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3723 -26.3769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8818 -25.7184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0726 -25.8138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0223 -28.6601 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.4818 -29.2730 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.4385 -26.4226 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 2 0
9 8 2 0
8 5 1 0
9 10 1 0
10 11 1 0
11 13 1 0
12 9 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
11 18 2 0
18 19 1 0
1 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 281.70 | Molecular Weight (Monoisotopic): 281.0356 | AlogP: 3.49 | #Rotatable Bonds: ┄ |
Polar Surface Area: 58.37 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.36 | CX Basic pKa: ┄ | CX LogP: 3.82 | CX LogD: 3.50 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.40 | Np Likeness Score: -0.74 |
References
1. Schepetkin IA, Khlebnikov AI, Potapov AS, Kovrizhina AR, Matveevskaya VV, Belyanin ML, Atochin DN, Zanoza SO, Gaidarzhy NM, Lyakhov SA, Kirpotina LN, Quinn MT.. (2019) Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors., 161 [PMID:30347329] [10.1016/j.ejmech.2018.10.023] |